Wellington-based cancer technology company Volpara Health Technologies has announced its latest contract – the highest value one to date – through its new US-based subsidiary.
The ASX-listed company announced on Friday a deal to provide its integrated breast cancer platform, which is
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive FREE offer for uni students studying at a New Zealand university (valued at $499).
